DNA secondary structure at chromosomal fragile sites in human disease

Current Genomics

Volumn 16, Issue 1, 2015, Pages 60-70

  Thys, Ryan G ^a   Lehman, Christine E ^a   Pierce, Levi C T ^b   Wang, Yuh Hwa ^c  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Human Longevity Inc   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Cancer; DNA fragility; DNA secondary structure; Fragile site; Genome instability; Neurological disease

Indexed keywords

BRCA1 PROTEIN; HISTONE H2AX;

ARTICLE; CELL CYCLE; CHROMATID EXCHANGE; CHROMOSOME; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; DNA REPAIR; DNA REPLICATION; DNA STRAND BREAKAGE; DNA STRUCTURE; DNA TRANSCRIPTION; GENE; GENE DELETION; GENE REARRANGEMENT; GENE SEQUENCE; GENOMIC INSTABILITY; HUMAN; NEOPLASM; NEUROLOGIC DISEASE; NONHUMAN; PROTEIN EXPRESSION; SMC5 GENE;

EID: 84926298943     PISSN: 13892029     EISSN: 18755488     Source Type: Journal    
DOI: 10.2174/1389202916666150114223205     Document Type: Article

References (141)

1. Choi J, Majima T, Conformational changes of non-B DNA. Chem. Soc. Rev., 2011, 40, 5893-5909.
2. Wells RD, Non-B DNA conformations, mutagenesis and disease. Trends Biochem. Sci., 2007, 32, 271-278.
3. Zhao, J.; Bacolla, A.; Wang, G.; Vasquez KM, Non-B DNA structure-induced genetic instability and evolution. Cell. Mol. Life Sci. CMLS, 2010, 67, 43-62.
4. Vasquez, K.M.; Wang, G. The yin and yang of repair mechanisms in DNA structure-induced genetic instability. Mutat. Res., 2013, 743-744, 118-131.
5. Ray, B.K.; Dhar, S.; Shakya, A.; Ray, A. Z-DNA-forming silencer in the first exon regulates human ADAM-12 gene expression. Proc. Natl. Acad. Sci. U S A., 2010, 108, 103-108.
6. Rimokh, R.; Rouault, J.P.; Wahbi, K.; Gadoux, M.; Lafage, M.; Archimbaud, E.; Charrin, C.; Gentilhomme, O.; Germain, D.; Samarut, J. A chromosome 12 coding region is juxtaposed to the MYC protooncogene locus in a t(8;12)(q24;q22) translocation in a case of B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer, 1991, 3, 24-36.
7. Wolfl, S.; Wittig, B.; Rich, A. Identification of transcriptionally induced Z-DNA segments in the human c-myc gene. Biochim. Biophys. Acta., 1995, 1264, 294-302.
8. Boehm, T.; Mengle-Gaw, L.; Kees, U.R.; Spurr, N.; Lavenir, I.; Forster, A.; Rabbitts, T.H. Alternating purine-pyrimidine tracts may promote chromosomal translocations seen in a variety of human lymphoid tumours. EMBO J., 1989, 8, 2621-2631.
9. Sinclair, P.B.; Parker, H.; An, Q.; Rand, V.; Ensor, H.; Harrison, C.J.; Strefford, J.C. Analysis of a breakpoint cluster reveals insight into the mechanism of intrachromosomal amplification in a lymphoid malignancy. Hum. Mol. Gene., 2011, 20, 2591-2602.
10. Nag, D.K.; Petes, T.D. Seven-base-pair inverted repeats in DNA form stable hairpins in vivo in Saccharomyces cerevisiae. Genetics, 1991, 129, 669-673.
11. Akgun, E.; Zahn, J.; Baumes, S.; Brown, G.; Liang, F.; Romanienko, P.J.; Lewis, S.; Jasin, M. Palindrome resolution and recombination in the mammalian germ line. Mol. Cell. Biol., 1997, 17, 5559-5570.
12. Zhou, Z.H.; Akgun, E.; Jasin, M. Repeat expansion by homologous recombination in the mouse germ line at palindromic sequences. Proc. Natl. Acad. Sci. U S A, 2001, 98, 8326-8333.
13. Tanaka, H.; Tapscott, S.J.; Trask, B.J.; Yao, M.C.; Short inverted repeats initiate gene amplification through the formation of a large DNA palindrome in mammalian cells. Proc. Natl. Acad. Sci. U S A, 2002, 99, 8772-8777.
14. Cunningham, L.A.; Cote, A.G.; Cam-Ozdemir, C.; Lewis, S.M. Rapid, stabilizing palindrome rearrangements in somatic cells by the center-break mechanism. Mol. Cell. Biol., 2003, 23, 8740-8750.
15. Kurahashi, H.; Shaikh, T.H.; Hu, P.; Roe, B.A.; Emanuel, B.S.; Budarf, M.L. Regions of genomic instability on 22q11 and 11q23 as the etiology for the recurrent constitutional t(11;22). Hum. Mol. Genet., 2000, 9, 1665-1670.
16. Edelmann, L.; Spiteri, E.; Koren, K.; Pulijaal, V.; Bialer, M.G.; Shanske, A.; Goldberg, R.; Morrow, B.E. AT-rich palindromes mediate the constitutional t(11;22) translocation. Am. J. Hum. Genet., 2001, 68, 1-13.
17. Kurahashi, H.; Emanuel, B.S. Long AT-rich palindromes and the constitutional t(11;22) breakpoint. Hum. Mol. Genet., 2001, 10, 2605-2617.
18. Kato, T.; Franconi, C.P.; Sheridan, M.B.; Hacker, A.M.; Inagakai, H.; Glover, T.W.; Arlt, M.F.; Drabkin, H.A.; Gemmill, R.M.; Kurahashi, H.; Emanuel, B.S. Analysis of the t(3;8) of hereditary renal cell carcinoma, a palindrome-mediated translocation. Cancer Genet., 2014, 207, 133-140.
19. Raghavan, S.C.; Swanson, P.C.; Wu, X.; Hsieh, C.L.; Lieber, M.R. A non-B-DNA structure at the Bcl-2 major breakpoint region is cleaved by the RAG complex. Nature, 2004, 428, 88-93.
20. Raghavan, S.C.; Chastain, P.; Lee, J.S.; Hegde, B.G.; Houston, S.; Langen, R.; Hsieh, C.L.; Haworth, I.S.; Lieber, M.R. Evidence for a triplex DNA conformation at the bcl-2 major breakpoint region of the t(14;18) translocation. J. Biol. Chem., 2005, 280, 22749-22760.
21. Belotserkovskii, B.P.; De Silva, E.; Tornaletti, S.; Wang, G.; Vasquez, K.M.; Hanawalt, P.C. A triplex-forming sequence from the human c-MYC promoter interferes with DNA transcription. J. Biol. Chem., 2007, 282, 32433-32441.
22. Bacolla, A.; Jaworski, A.; Larson, J.E.; Jakupciak, J.P.; Chuzhanova, N.; Abeysinghe, S.S.; O'Connell, C.D.; Cooper, D.N.; Wells, R.D. Breakpoints of gross deletions coincide with non-B DNA conformations. Proc. Natl. Acad. Sci. U S A., 2004, 101, 14162-14167.
23. Bacolla, A.; Wojciechowska, M.; Kosmider, B.; Larson, J.E.; Wells, R.D. The involvement of non-B DNA structures in gross chromosomal rearrangements. DNA Repair, 2006, 5, 1161-1170.
24. Bacolla, A.; Wells, R.D. Non-B DNA conformations as determinants of mutagenesis and human disease. Mol. Carcinogenesis, 2009, 48, 273-285.
25. Wu, Y.; Brosh, R.M, Jr., G-quadruplex nucleic acids and human disease. FEBS. J., 2010, 277, 3470-3488.
26. Besnard, E.; Babled, A.; Lapasset, L.; Milhavet, O.; Parrinello, H.; Dantec, C.; Marin, J.M.; Lemaitre, J.M. Unraveling cell typespecific and reprogrammable human replication origin signatures associated with G-quadruplex consensus motifs. Nat. Struct. Mol. Biol., 2012, 19, 837-844.
27. Lopes, J.; Piazza, A.; Bermejo, R.; Kriegsman, B.; Colosio, A.; Teulade-Fichou, M.P.; Foiani, M.; Nicolas, A. G-quadruplexinduced instability during leading-strand replication. EMBO. J., 2011, 30, 4033-4046.
28. Paeschke, K.; Capra, J.A.; Zakian, V.A. DNA replication through G-quadruplex motifs is promoted by the Saccharomyces cerevisiae Pif1 DNA helicase. Cell, 2011, 145, 678-691.
29. Zahler, A.M.; Williamson, J.R.; Cech, T.R.; Prescott, D.M. Inhibition of telomerase by G-quartet DNA structures. Nature, 1991, 350, 718-720.
30. De, S.; Michor, F. DNA secondary structures and epigenetic determinants of cancer genome evolution. Nat. Struct. Mol. Biol., 2011, 18, 950-955.
31. Bose, P.; Hermetz, K.E.; Conneely, K.N.; Rudd, M.K. Tandem repeats and G-rich sequences are enriched at human CNV breakpoints. PloS One, 2014, 9, e101607.
32. Reddy, K.; Zamiri, B.; Stanley, S.Y.; Macgregor, R.B, Jr., Pearson CE, The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni-and multimolecular RNA G-quadruplex structures. J. Biol. Chem., 2013, 288, 9860-9866.
33. Haeusler, A.R.; Donnelly, C.J.; Periz, G.; Simko, E.A.; Shaw, P.G.; Kim, M.S.; Maragakis, N.J.; Troncoso, J.C.; Pandey, A.; Sattler, R.; Rothstein, J.D.; Wang, J. C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature, 2014, 507, 195-200.
34. DeJesus-Hernandez, M.; Mackenzie, I.R.; Boeve, B.F.; Boxer, A.L.; Baker, M.; Rutherford, N.J.; Nicholson, A.M.; Finch, N.A.; Flynn, H.; Adamson, J.; Kouri, N.; Wojtas, A.; Sengdy, P.; Hsiung, G.Y.; Karydas, A.; Seeley, W.W.; Josephs, K.A.; Coppola, G.; Geschwind, D.H.; Wszolek, Z.K.; Feldman, H.; Knopman, D.S.; Petersen, R.C.; Miller, B.L.; Dickson, D.W.; Boylan, K.B.; Graff-Radford, N.R.; Rademakers, R. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron, 2011, 72, 245-256.
35. Renton, A.E.; Majounie, E.; Waite, A.; Simon-Sanchez, J.; Rollinson, S.; Gibbs, J.R.; Schymick, J.C.; Laaksovirta, H.; van Swieten, J.C.; Myllykangas, L.; Kalimo, H.; Paetau, A.; Abramzon, Y.; Remes, A.M.; Kaganovich, A.; Scholz, S.W.; Duckworth, J.; Ding, J.; Harmer, D.W.; Hernandez, D.G.; Johnson, J.O.; Mok, K.; Ryten, M.; Trabzuni, D.; Guerreiro, R.J.; Orrell, R.W.; Neal, J.; Murray, A.; Pearson, J.; Jansen, I.E.; Sondervan, D.; Seelaar, H.; Blake, D.; Young, K.; Halliwell, N.; Callister, J.B.; Toulson, G.; Richardson, A.; Gerhard, A.; Snowden, J.; Mann, D.; Neary, D.; Nalls, M.A.; Peuralinna, T.; Jansson, L.; Isoviita, V.M.; Kaivorinne, A.L.; Hölttä-Vuori, M., Ikonen, E.; Sulkava, R.; Benatar, M.; Wuu, J.; Chiò, A.; Restagno, G.; Borghero, G.; Sabatelli, M.; ITALSGEN Consortium.; Heckerman, D.; Rogaeva, E.; Zinman, L.; Rothstein, J.D.; Sendtner, M.; Drepper, C.; Eichler, E.E.; Alkan, C.; Abdullaev, Z.; Pack, S.D.; Dutra, A.; Pak, E.; Hardy, J.; Singleton, A.; Williams, N.M.; Heutink, P.; Pickering-Brown, S.; Morris, H.R.; Tienari, P.J.; Traynor, B.J. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron, 2011, 72, 257-268.
36. Kobayashi, H.; Abe, K.; Matsuura, T.; Ikeda, Y.; Hitomi, T.; Akechi, Y.; Habu, T.; Liu, W.; Okuda, H.; Koizumi, A. Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement. Am. J. Hum. Genet., 2011, 89, 121-130.
37. Borel, C.; Migliavacca, E.; Letourneau, A.; Gagnebin, M.; Bena, F.; Sailani, M.R.; Dermitzakis, E.T.; Sharp, A.J.; Antonarakis, S.E. Tandem repeat sequence variation as causative cis-eQTLs for protein-coding gene expression variation, the case of CSTB. Hum. Mutat., 2012, 33, 1302-1309.
38. Mead, S.; Webb, T.E.; Campbell, T.A.; Beck, J.; Linehan, J.M.; Rutherfoord, S.; Joiner, S.; Wadsworth, J.D.; Heckmann, J.; Wroe, S. Inherited prion disease with 5-OPRI, phenotype modification by repeat length and codon 129. Neurology, 2007, 69, 730-738.
39. Fan, H.C.; Ho, LI.; Chi, C.S.; Chen, S.J.; Peng, G.S.; Chan, T.M.; Lin, S.Z.; Harn, H.J. Polyglutamine (PolyQ) Diseases, Genetics to Treatments. Cell Transplant, 2014, 23, 441-458.
40. Cleary, J.D.; Nichol, K.; Wang, Y.H. Pearson CE, Evidence of cisacting factors in replication-mediated trinucleotide repeat instability in primate cells. Nat. Genet, 2002, 31, 37-46.
41. Lahue, R.S.; Slater, D.L. DNA repair and trinucleotide repeat instability. Front. Biosci., 2003, 8, s653-665.
42. Fry, M.; Loeb, L.A. The fragile X syndrome d(CGG)n nucleotide repeats form a stable tetrahelical structure. Proc. Natl. Acad. Sci. U S A., 1994, 91, 4950-4954.
43. Gacy, A.M.; Goellner, G.; Juranic, N.; Macura, S.; McMurray, C.T. Trinucleotide repeats that expand in human disease form hairpin structures in vitro. Cell, 1995, 81, 533-540.
44. Usdin, K.; Woodford, K.J. CGG repeats associated with DNA instability and chromosome fragility form structures that block DNA synthesis in vitro. Nucleic Acids Res., 1995, 23, 4202-4209.
45. Samadashwily, G.M.; Raca, G.; Mirkin, S.M. Trinucleotide repeats affect DNA replication in vivo. Nat. Genet, 1997, 17, 298-304.
46. Rajeswari, M.R. DNA triplex structures in neurodegenerative disorder, Friedreich's ataxia. J. Biosci., 2012, 37, 519-532.
47. Jarem, D.A.; Huckaby, L.V.; Delaney, S. AGG interruptions in (CGG)(n) DNA repeat tracts modulate the structure and thermodynamics of non-B conformations in vitro. Biochemistry, 2010, 49, 6826-6837.
48. Pearson, C.E.; Eichler, E.E.; Lorenzetti, D.; Kramer, S.F.; Zoghbi, H.Y.; Nelson, D.L.; Sinden, R.R. Interruptions in the triplet repeats of SCA1 and FRAXA reduce the propensity and complexity of slipped strand DNA (S-DNA) formation. Biochemistry, 1998, 37, 2701-2708.
49. Weisman-Shomer, P.; Cohen, E.; Fry, M. Interruption of the fragile X syndrome expanded sequence d(CGG)(n) by interspersed d(AGG) trinucleotides diminishes the formation and stability of d(CGG)(n) tetrahelical structures. Nucleic Acids Res., 2000, 28, 1535-1541.
50. Richards, R.I. Fragile and unstable chromosomes in cancer, causes and consequences. Trends in Genetics, TIG 2001, 17, 339-345.
51. Glover, T.W. Common fragile sites. Cancer Lett., 2006, 232, 4-12.
52. Cheng, C.H.; Kuchta, R.D. DNA polymerase epsilon, aphidicolin inhibition and the relationship between polymerase and exonuclease activity. Biochemistry, 1993, 32, 8568-8574.
53. Glover, T.W.; Berger, C.; Coyle, J.; Echo, B. DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum. Gene., 1984, 67, 136-142.
54. Dillon, L.W.; Burrow, A.A.; Wang, Y.H. DNA instability at chromosomal fragile sites in cancer. Curr. Genom., 2010, 11, 326-337.
55. Durkin, S.G.; Glover, T.W. Chromosome fragile sites. Annu. Rev. Genet, 2007, 41, 169-192.
56. Kremer, E.J.; Pritchard, M.; Lynch, M.; Yu, S.; Holman, K. Baker, E.; Warren, S.T.; Schlessinger, D.; Sutherland, G.R.; Richards, R.I. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science, 1991, 252, 1711-1714.
57. Pieretti, M.; Zhang, F.P.; Fu, Y.H.; Warren, S.T.; Oostra, B.A.; Caskey, C.T.; Nelson, D.L. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell, 1991, 66, 817-822.
58. Verkerk, A.J.; Pieretti, M.; Sutcliffe, J.S.; Fu, Y.H.; Kuhl, D.P.; Pizzuti, A.; Reiner, O.; Richards, S.; Victoria, M.F.; Zhang, F.P. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell, 1991, 65, 905-914.
59. Sofola, O.A.; Jin, P.; Botas, J.; Nelson, D.L. Argonaute-2-dependent rescue of a Drosophila model of FXTAS by FRAXE premutation repeat. Hum. Mol. Gene., 2007, 16, 2326-2332.
60. Jones, C.; Mullenbach, R.; Grossfeld, P.; Auer, R.; Favier, R.; Chien, K.; James, M.; Tunnacliffe, A.; Cotter, F. Co-localisation of CCG repeats and chromosome deletion breakpoints in Jacobsen syndrome, evidence for a common mechanism of chromosome breakage. Hum. Mol. Gene., 2000, 9, 1201-1208.
61. Demirhan, O.; Tastemir, D.; Sertdemir, Y. The expression of folate sensitive fragile sites in patients with bipolar disorder. Yonsei, Med. J., 2009, 50, 137-141.
62. Smith, C.L.; Bolton, A.; Nguyen, G. Genomic and epigenomic instability, fragile sites, schizophrenia and autism. Curr. Genomics, 2011, 11, 447-469.
63. Burrow, A.A.; Williams, L.E.; Pierce, L.C.; Wang, Y.H. Over half of breakpoints in gene pairs involved in cancer-specific recurrent translocations are mapped to human chromosomal fragile sites. BMC Genomics, 2009, 10, 59.
64. Arlt, M.F.; Durkin, S.G.; Ragland, R.L.; Glover, T.W. Common fragile sites as targets for chromosome rearrangements. DNA Repair, 2006, 5, 1126-1135.
65. Ohta, M.; Inoue, H.; Cotticelli, M.G.; Kastury, K.; Baffa, R.; Palazzo, J.; Siprashvili, Z.; Mori, M.; McCue, P.; Druck, T. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell, 1996, 84, 587-597.
66. Poulogiannis, G.; McIntyre, R.E.; Dimitriadi, M.; Apps, J.R.; Wilson, C.H.; Ichimura, K.; Luo, F.; Cantley, L.C.; Wyllie, A.H.; Adams, D.J.; Arends, M.J. PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice. Proc. Natl. Acad. Sci. U S A, 2010, 107, 15145-15150.
67. Gao, G.; Kasperbauer, J.L.; Tombers, N.M.; Wang, V.; Mayer, K.; Smith, D.I. A selected group of large common fragile site genes have decreased expression in oropharyngeal squamous cell carcinomas. Genes, Chromosomes & Cancer, 2014, 53, 392-401.
68. Feitelson, M.A.; Lee, J. Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer Lett., 2007, 252, 157-170.
69. Jiang, S.; Yang, Z.; Li, W.; Li, X.; Wang, Y.; Zhang, J.; Xu, C.; Chen, P.J.; Hou, J.; McCrae, M.A. Re-evaluation of the carcinogenic significance of hepatitis B virus integration in hepatocarcinogenesis. PloS One, 2012, 7, e40363.
70. Ragin, C.C.; Reshmi, S.C.; Gollin, S.M. Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line. International J. Cancer J. International Du Cancer, 2004, 110, 701-709.
71. Dall, K.L.; Scarpini, C.G.; Roberts, I.; Winder, D.M.; Stanley, M.A.; Muralidhar, B.; Herdman, M.T.; Pett, M.R.; Coleman, N. Characterization of naturally occurring HPV16 integration sites isolated from cervical keratinocytes under noncompetitive conditions. Cancer Res., 2008, 68, 8249-8259.
72. Matovina, M.; Sabol, I.; Grubisic, G.; Gasperov, N.M.; Grce, M. Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions. Gynecol. Oncol., 2009, 113, 120-127.
73. Gandhi, M.; Dillon, L.W.; Pramanik, S.; Nikiforov, Y.E.; Wang, Y.H. DNA breaks at fragile sites generate oncogenic RET/PTC rearrangements in human thyroid cells. Oncogene, 2010, 29, 2272-2280.
74. Burrow, A.A.; Marullo, A.; Holder, L.R.; Wang, Y.H. Secondary structure formation and DNA instability at fragile site FRA16B. Nucleic Acids Res., 2010, 38, 2865-2877.
75. Mirkin, S.M. DNA structures, repeat expansions and human hereditary disorders. Curr. Opin. Struct. Biol., 2006, 16, 351-358.
76. Balakumaran, B.S.; Freudenreich, C.H.; Zakian, V.A. CGG/CCG repeats exhibit orientation-dependent instability and orientationindependent fragility in Saccharomyces cerevisiae. Hum. Mol. Gene., 2000, 9, 93-100.
77. Zhang, H.; Freudenreich, C.H. An AT-rich sequence in human common fragile site FRA16D causes fork stalling and chromosome breakage in S. cervisiae. Mol. Cell, 2007, 27, 367-379.
78. Savelyeva, L.; Brueckner, L.M. Molecular characterization of common fragile sites as a strategy to discover cancer susceptibility genes. Cellular and molecular life sciences , CMLS, 2014, 71, 4561-4575.
79. Dillon, L.W.; Pierce, L.C.; Ng, M.C.; Wang, Y.H. Role of DNA secondary structures in fragile site breakage along human chromosome 10. Hum. Mol. Gene., 2013, 22, 1443-1456.
80. Zuker, M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res., 2003, 31, 3406-3415.
81. Huppert, J.L.; Balasubramanian, S. G-quadruplexes in promoters throughout the human genome. Nucleic Acids Res., 2007, 35, 406-413.
82. Katapadi, V.K.; Nambiar, M.; Raghavan, S.C. Potential Gquadruplex formation at breakpoint regions of chromosomal translocations in cancer may explain their fragility. Genomics, 2012, 100, 72-80.
83. Fungtammasan, A.; Walsh, E.; Chiaromonte, F.; Eckert, K.A.; Makova, K.D. A genome-wide analysis of common fragile sites, What features determine chromosomal instability in the human genome? Genome. Res., 2012, 22, 993-1005.
84. Shah, S.N.; Opresko, P.L.; Meng, X.; Lee, M.Y.; Eckert, K.A. DNA structure and the Werner protein modulate human DNA polymerase delta-dependent replication dynamics within the common fragile site FRA16D. Nucleic Acids Res., 2010, 38, 1149-1162.
85. Casper, A.M.; Nghiem, P.; Arlt, M.F.; Glover, T.W. ATR regulates fragile site stability. Cell, 2002, 111, 779-789.
86. Casper, A.M.; Durkin, S.G.; Arlt, M.F.; Glover, T.W. Chromosomal instability at common fragile sites in Seckel syndrome. Am. J. Hum. Genet., 2004, 75, 654-660.
87. Cimprich, K.A.; Cortez D. ATR, an essential regulator of genome integrity. Nat. Rev. Mol. Cell Biol., 2008, 9, 616-627.
88. Wan, C.; Kulkarni, A.; Wang, Y.H. ATR preferentially interacts with common fragile site FRA3B and the binding requires its kinase activity in response to aphidicolin treatment. Mutat. Res., 2010, 686, 39-46.
89. Ozeri-Galai, E.; Schwartz, M.; Rahat, A.; Kerem, B. Interplay between ATM and ATR in the regulation of common fragile site stability. Oncogene, 2008, 27, 2109-2117.
90. Arlt, M.F.; Xu, B.; Durkin, S.G.; Casper, A.M.; Kastan, M.B.; Glover, T.W. BRCA1 is required for common-fragile-site stability via its G 2/M checkpoint function. Mol. Cell. Biol., 2004, 24, 6701-6709.
91. Durkin, S.G.; Arlt, M.F.; Howlett, N.G.; Glover, T.W. Depletion of CHK1, but not CHK2, induces chromosomal instability and breaks at common fragile sites. Oncogene, 2006, 25, 4381-4388.
92. Musio, A.; Montagna, C.; Mariani, T.; Tilenni, M.; Focarelli, M.L.; Brait, L.; Indino, E.; Benedetti, P.A.; Chessa, L.; Albertini, A. SMC1 involvement in fragile site expression. Hum. Mol. Gene., 2005, 14, 525-533.
93. Zhu, M.; Weiss, R.S. Increased common fragile site expression, cell proliferation defects, and apoptosis following conditional inactivation of mouse Hus1 in primary cultured cells. Mol. Biol. Cell, 2007, 18, 1044-1055.
94. Focarelli, M.L.; Soza, S.; Mannini, L.; Paulis, M.; Montecucco, A.; Musio, A. Claspin inhibition leads to fragile site expression. Genes, Chromosomes & Cancer, 2009, 48, 1083-1090.
95. Howlett, N.G.; Taniguchi, T.; Durkin, S.G.; D'Andrea, A.D.; Glover, T.W. The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. Hum. Mol. Gene., 2005, 14, 693-701.
96. Schwartz, M.; Zlotorynski, E.; Goldberg, M.; Ozeri, E.; Rahat, A.; le Sage, C.; Chen, B.P.; Chen, D.J.; Agami, R.; Kerem, B. Homologous recombination and nonhomologous end-joining repair pathways regulate fragile site stability. Genes. Dev., 2005, 19, 2715-2726.
97. Rey, L.; Sidorova, J.M.; Puget, N.; Boudsocq, F.; Biard, D.S.; Monnat, R.J, Jr., Cazaux, C.; Hoffmann, J.S. Human DNA polymerase eta is required for common fragile site stability during unperturbed DNA replication. Mol. Cell Biol., 2009, 29, 3344-3354.
98. Bhat, A.; Andersen, P.L.; Qin, Z.; Xiao, W. Rev3, the catalytic subunit of Polzeta, is required for maintaining fragile site stability in human cells. Nucleic Acids Res., 2013, 41, 2328-2339.
99. Walsh, E.; Wang, X.; Lee, M.Y.; Eckert, K.A. Mechanism of replicative DNA polymerase delta pausing and a potential role for DNA polymerase kappa in common fragile site replication. J. Mol. Biol., 2013, 425, 232-243.
100. Costanzo, V.; Shechter, D.; Lupardus, P.J.; Cimprich, K.A.; Gottesman, M.; Gautier, J. An ATR-and Cdc7-dependent DNA damage checkpoint that inhibits initiation of DNA replication. Mol. Cell, 2003, 11, 203-213.
101. Zou, L.; Elledge, S.J. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science, 2003, 300, 1542-1548.
102. Choi, J.H.; Lindsey-Boltz, L.A.; Kemp, M.; Mason, A.C.; Wold, M.S.; Sancar, A. Reconstitution of RPA-covered single-stranded DNA-activated ATR-Chk1 signaling. Proc. Natl. Acad. Sci. U S A, 2010, 107, 13660-13665.
103. Kim, C.; Paulus, B.F.; Wold, M.S. Interactions of human replication protein A with oligonucleotides. Biochemistry, 1994, 33, 14197-14206.
104. Fernandez-Capetillo, O.; Nussenzweig, A. Naked replication forks break apRPArt. Cell, 2013, 155, 979-980.
105. Toledo, L.I.; Altmeyer, M.; Rask, M.B.; Lukas, C.; Larsen, D.H.; Povlsen, L.K.; Bekker-Jensen, S.; Mailand, N.; Bartek, J.; Lukas, J. ATR prohibits replication catastrophe by preventing global exhaustion of RPA. Cell, 2013, 155, 1088-1103.
106. Pirzio, L.M.; Pichierri, P.; Bignami, M.; Franchitto, A. Werner syndrome helicase activity is essential in maintaining fragile site stability. J. Cell. Biol., 2008, 180, 305-314.
107. Pellicioli, A.; Muzi-Falconi, M. A blooming resolvase at chromosomal fragile sites. Nat. Cell Biol., 2013, 15, 883-885.
108. Pichierri, P.; Rosselli, F.; Franchitto, A. Werner's syndrome protein is phosphorylated in an ATR/ATM-dependent manner following replication arrest and DNA damage induced during the S phase of the cell cycle. Oncogene, 2003, 22, 1491-1500.
109. Bacolla, A.; Wang, G.; Jain, A.; Chuzhanova, N.A.; Cer, R.Z.; Collins, J.R.; Cooper, D.N.; Bohr, V.A.; Vasquez, K.M. Non-B DNA-forming sequences and WRN deficiency independently increase the frequency of base substitution in human cells. J. Biol. Chem., 2011, 286, 10017-10026.
110. Kamath-Loeb, A.S.; Shen, J.C.; Schmitt, M.W.; Loeb, L.A. The Werner syndrome exonuclease facilitates DNA degradation and high fidelity DNA polymerization by human DNA polymerase delta. J.Biol. Chem., 2012, 287, 12480-12490.
111. Lu, X.; Parvathaneni, S.; Hara, T.; Lal, A.; Sharma, S. Replication stress induces specific enrichment of RECQ1 at common fragile sites FRA3B and FRA16D. Mol. Cancer, 2013, 12, 29.
112. Naim, V.; Wilhelm, T.; Debatisse, M.; Rosselli, F. ERCC1 and MUS81-EME1 promote sister chromatid separation by processing late replication intermediates at common fragile sites during mitosis. Nat. Cell Biol., 2013, 15, 1008-1015.
113. Ying, S.; Minocherhomji, S.; Chan, K.L.; Palmai-Pallag, T.; Chu, W.K.; Wass, T.; Mankouri, H.W.; Liu, Y.; Hickson, I.D. MUS81 promotes common fragile site expression. Nat. Cell Biol., 2013, 15, 1001-1007.
114. Minocherhomji, S.; Hickson, I.D. Structure-specific endonucleases, guardians of fragile site stability. Trends in Cell Biol., 2014, 24, 321-327.
115. Pepe, A.; West, S.C. MUS81-EME2 promotes replication fork restart. Cell Reports, 2014, 7, 1048-1055.
116. Wang, H.; Li, Y.; Truong, L.N.; Shi, L.Z.; Hwang, P.Y.; He, J.; Do, J.; Cho, M.J.; Li, H.; Negrete, A. CtIP Maintains Stability at Common Fragile Sites and Inverted Repeats by End Resection-Independent Endonuclease Activity. Mol. Cell, 2014, 56, 1012-1021.
117. Mason, J.M.; Das, I.; Arlt, M.; Patel, N.; Kraftson, S.; Glover, T.W.; Sekiguchi, J.M. The SNM1B/APOLLO DNA nuclease functions in resolution of replication stress and maintenance of common fragile site stability. Hum. Mol. Gene., 2013, 22, 4901-4913.
118. Inagaki, H.; Ohye, T.; Kogo, H.; Tsutsumi, M.; Kato, T.; Tong, M.; Emanuel, B.S.; Kurahashi, H. Two sequential cleavage reactions on cruciform DNA structures cause palindrome-mediated chromosomal translocations. Nat. Commun, 2013, 4, 1592.
119. Vos, S.M.; Tretter, E.M.; Schmidt, B.H.; Berger, J.M. All tangled up, how cells direct, manage and exploit topoisomerase function. Nat. Rev. Mol. Cell Biol., 2011, 12, 827-841.
120. Been, M.D.; Champoux, J.J. Breakage of single-stranded DNA by eukaryotic type 1 topoisomerase occurs only at regions with the potential for base-pairing. J. Mol. Biol., 1984, 180, 515-531.
121. Froelich-Ammon, S.J.; Gale, K.C.; Osheroff, N. Site-specific cleavage of a DNA hairpin by topoisomerase II. DNA secondary structure as a determinant of enzyme recognition/cleavage. J. Biol. Chem., 1994, 269, 7719-7725.
122. Jonstrup, A.T.; Thomsen, T.; Wang, Y.; Knudsen, B.R.; Koch, J.; Andersen, A.H. Hairpin structures formed by alpha satellite DNA of human centromeres are cleaved by human topoisomerase IIalpha. Nucleic Acids Res., 2008, 36, 6165-6174.
123. Arlt, M.F.; Glover, T.W.; Inhibition of topoisomerase I prevents chromosome breakage at common fragile sites. DNA Repair, 2010, 9, 678-689.
124. Helmrich, A.; Ballarino, M.; Tora, L. Collisions between replication and transcription complexes cause common fragile site instability at the longest human genes. Mol. Cell, 2011, 44, 966-977.
125. Hashash, N.; Johnson, A.L.; Cha, R.S. Topoisomerase II-and condensin-dependent breakage of MEC1ATR-sensitive fragile sites occurs independently of spindle tension, anaphase, or cytokinesis. PLoS Gene., 2012, 8, e1002978.
126. Dillon, L.W.; Pierce, L.C.; Lehman, C.E.; Nikiforov, Y.E.; Wang, Y.H. DNA topoisomerases participate in fragility of the oncogene RET. PloS one, 2013, 8, e75741.
127. Ozeri-Galai, E.; Lebofsky, R.; Rahat, A.; Bester, A.C.; Bensimon, A.; Kerem, B. Failure of origin activation in response to fork stalling leads to chromosomal instability at fragile sites. Molecular cell, 2011, 43, 122-131.
128. Letessier, A.; Millot, G.A.; Koundrioukoff S, Lachages, AM.; Vogt N, Hansen RS, Malfoy B, Brison O, Debatisse M, Cell-typespecific replication initiation programs set fragility of the FRA3B fragile site. Nature, 2011, 470, 120-123.
129. Debatisse, M.; Le Tallec, B.; Letessier, A.; Dutrillaux B, Brison O, Common fragile sites, mechanisms of instability revisited. Trends in genetics , TIG 2012, 28, 22-32.
130. Grabczyk, E.; Mancuso, M.; Sammarco, M.C. A persistent RNA.DNA hybrid formed by transcription of the Friedreich ataxia triplet repeat in live bacteria, and by T7 RNAP in vitro. Nucleic Acids Res., 2007, 35, 5351-5359.
131. Lin, Y.; Dent, SY.; Wilson, JH.; Wells, RD.; Napierala, M. R loops stimulate genetic instability of CTG.CAG repeats. Proc. Natl. Acad. Sci. U S A, 2010, 107, 692-697.
132. Reddy, K.; Tam, M.; Bowater, R.P.; Barber, M.; Tomlinson, M.; Nichol, Edamura K.; Wang, Y.H.; Pearson, CE. Determinants of Rloop formation at convergent bidirectionally transcribed trinucleotide repeats. Nucleic Acids Res., 2011, 39, 1749-1762.
133. Lin, Y.; Wilson, J.H. Transcription-induced DNA toxicity at trinucleotide repeats, double bubble is trouble. Cell Cycle, 2011, 10, 611-618.
134. Barlow, J.H.; Faryabi, R.B.; Callen, E.; Wong, N.; Malhowski, A.; Chen, H.T.; Gutierrez-Cruz, G,; Sun, H.W.; McKinnon, P.; Wright G, Casellas, R.; Robbiani, D.F.; Staudt, L.; Fernandez-Capetillo, O.; Nussenzweig, A. Identification of early replicating fragile sites that contribute to genome instability. Cell, 2013, 152, 620-632.
135. Le Tallec, B.; Koundrioukoff, S.; Wilhelm, T.; Letessier, A.; Brison O, Debatisse M, Updating the mechanisms of common fragile site instability, how to reconcile the different views? Cell. molecular life sci. , CMLS, 2014, 71, 4489-4494.
136. Mirkin, E.V.; Mirkin, S.M. To switch or not to switch, at the origin of repeat expansion disease. Mol. cell, 2014, 53, 1-3.
137. Ozeri-Galai E, Tur-Sinai M, Bester AC, Kerem B, Interplay between genetic and epigenetic factors governs common fragile site instability in cancer. Cell. Mol. Life Sci. , CMLS, 2014, 71, 4495-4506.
138. Coquelle A, Rozier L, Dutrillaux B, Debatisse M, Induction of multiple double-strand breaks within an hsr by meganucleaseI-SceI expression or fragile site activation leads to formation of double Current Genomics, 2015, Vol. 16, No. 1 Thys et al. minutes and other chromosomal rearrangements. Oncogene, 2002, 21, 7671-7679.
139. Debatisse, M.; Coquelle, A.; Toledo, F.; Buttin, G. Gene amplification mechanisms, the role of fragile sites. Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches sur le cancer, 1998, 154, 216-226.
140. Franchitto, A.; Pichierri, P. Replication fork recovery and regulation of common fragile sites stability. Cell. mol. life sci., CMLS, 2014, 71, 4507-4517.
141. Franchitto, A. Genome instability at common fragile sites, searching for the cause of their instability. BioMed. Res. Int., 2013, 2013, 730714.